CARsgen Therapeutics Holdings Limited (HKG:2171)

HKG:2171 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	6,042	8,254	5,060	3,742	8,578	15,607
Market Cap Growth	15.08%	63.11%	35.24%	-56.38%	-45.04%	-
Enterprise Value	4,855	7,026	3,513	1,505	5,764	11,806
Last Close Price	10.87	14.85	9.21	6.50	14.98	27.50
PS Ratio	43.20	59.02	120.61	-	-	492.57
PB Ratio	6.97	9.52	4.50	1.89	3.07	4.24
P/TBV Ratio	6.94	9.48	4.51	1.89	3.09	4.27
EV/Sales Ratio	34.72	50.25	83.74	-	-	372.60
Debt / Equity Ratio	0.08	0.08	0.16	0.05	0.05	0.11
Net Debt / Equity Ratio	-1.36	-1.36	-1.24	-0.98	-0.87	-0.89
Net Debt / EBITDA Ratio	27.18	27.18	1.91	2.46	2.88	4.84
Net Debt / FCF Ratio	4.48	4.48	3.07	3.81	2.77	3.89
Asset Turnover	0.09	0.09	0.02	-	-	0.01
Inventory Turnover	6.50	6.50	6.49	-	-	-
Quick Ratio	5.62	5.62	5.96	9.49	13.40	7.87
Current Ratio	5.73	5.73	6.03	9.55	13.45	7.89
Return on Equity (ROE)	-11.21%	-11.21%	-55.84%	-34.98%	-32.62%	-718.56%
Return on Assets (ROA)	-4.39%	-4.39%	-23.91%	-19.55%	-16.06%	-15.43%
Return on Capital Employed (ROCE)	-9.60%	-9.60%	-53.00%	-38.10%	-31.10%	-18.80%
Earnings Yield	-1.80%	-1.32%	-16.79%	-22.02%	-11.76%	-37.31%
FCF Yield	-	-3.19%	-9.00%	-13.66%	-10.26%	-5.41%
Buyback Yield / Dilution	1.67%	1.67%	0.58%	-0.82%	-42.60%	-95.23%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.